FibroBiologics, Inc. (FBLG)
1.36
-0.07
(-4.90%)
USD |
NASDAQ |
Sep 21, 16:00
1.32
-0.04
(-2.94%)
After-Hours: 20:00
FibroBiologics Price to Book Value : 1.784 for Sept. 21, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 21, 2026 | 1.784 |
| September 18, 2026 | 1.876 |
| September 17, 2026 | 1.948 |
| September 16, 2026 | 1.876 |
| September 15, 2026 | 1.889 |
| September 14, 2026 | 2.033 |
| September 11, 2026 | 2.112 |
| September 10, 2026 | 2.269 |
| September 09, 2026 | 2.308 |
| September 08, 2026 | 2.243 |
| September 04, 2026 | 2.374 |
| September 03, 2026 | 2.308 |
| September 02, 2026 | 2.558 |
| September 01, 2026 | 2.768 |
| August 31, 2026 | 2.256 |
| August 28, 2026 | 1.889 |
| August 27, 2026 | 1.954 |
| August 26, 2026 | 1.849 |
| August 25, 2026 | 1.836 |
| August 24, 2026 | 1.771 |
| August 21, 2026 | 1.889 |
| August 20, 2026 | 1.692 |
| August 19, 2026 | 1.561 |
| August 18, 2026 | 1.495 |
| August 17, 2026 | 1.338 |
| Date | Value |
|---|---|
| August 14, 2026 | 1.390 |
| August 13, 2026 | 1.508 |
| August 12, 2026 | 1.456 |
| August 11, 2026 | 1.351 |
| August 10, 2026 | 1.285 |
| August 07, 2026 | 1.280 |
| August 06, 2026 | 1.338 |
| August 05, 2026 | 1.138 |
| August 04, 2026 | 1.078 |
| August 03, 2026 | 1.037 |
| July 31, 2026 | 0.9181 |
| July 30, 2026 | 0.9433 |
| July 29, 2026 | 0.8586 |
| July 28, 2026 | 0.8531 |
| July 27, 2026 | 0.8225 |
| July 24, 2026 | 0.9339 |
| July 23, 2026 | 0.9647 |
| July 22, 2026 | 0.9707 |
| July 21, 2026 | 1.014 |
| July 20, 2026 | 1.024 |
| July 17, 2026 | 1.095 |
| July 16, 2026 | 1.102 |
| July 15, 2026 | 1.105 |
| July 14, 2026 | 1.117 |
| July 13, 2026 | 1.126 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.477 |
| Alnylam Pharmaceuticals, Inc. | 24.13 |
| Anika Therapeutics, Inc. | 2.018 |
| Savara, Inc. | 7.792 |
| Vericel Corp. | 5.469 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0084 |
| Price | 1.36 |
| Earnings Yield | -414.7% |
| Market Cap | 8.270M |
| PEGY Ratio | -0.0084 |